We are live on
!
Find out more
Bristol-Myers Squibb
BMY
BMY
1,600 hedge funds and large institutions have $69.4B invested in Bristol-Myers Squibb in 2016 Q4 according to their latest regulatory filings, with 203 funds opening new positions, 563 increasing their positions, 633 reducing their positions, and 102 closing their positions.
New
Increased
Maintained
Reduced
Closed
99% more first-time investments, than exits
New positions opened: 203 | Existing positions closed: 102
20% more funds holding in top 10
Funds holding in top 10: 49 → 59 (+10)
10% more capital invested
Capital invested by funds: $63.3B → $69.4B (+$6.1B)
5% more funds holding
Funds holding: 1,521 → 1,600 (+79)
8% more call options, than puts
Call options by funds: $1.49B | Put options by funds: $1.38B
0.16% more ownership
Funds ownership: 70.8% → 70.96% (+0.16%)
11% less repeat investments, than reductions
Existing positions increased: 563 | Existing positions reduced: 633
Holders
1,600
Holders Change
+79
Holders Change %
+5.19%
% of All Funds
40.01%
Holding in Top 10
59
Holding in Top 10 Change
+10
Holding in Top 10 Change %
+20.41%
% of All Funds
1.48%
New
203
Increased
563
Reduced
633
Closed
102
Calls
$1.49B
Puts
$1.38B
Net Calls
+$115M
Net Calls Change
+$343M
Top Buyers
| 1 |
Dodge & Cox
San Francisco,
California
|
+$1.23B |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$838M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$646M |
| 4 |
JP
Jana Partners
New York
|
+$212M |
| 5 |
Jennison Associates
New York
|
+$191M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$444M |
| 2 |
Morgan Stanley
New York
|
-$366M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$258M |
| 4 |
Renaissance Technologies
New York
|
-$227M |
| 5 |
JP Morgan Chase
New York
|
-$218M |
